RYALTRIS

OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE · HIKMA SPECIALTY USA INC.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for RYALTRIS, covering 2022-01-13 to 2023-08-29. Get the full timeline:

Most recent: FDA Approved: RYALTRIS — Supplemental Application (HIKMA SPECIALTY USA INC.)